ABEO
Price
$6.27
Change
-$0.01 (-0.16%)
Updated
Jun 3 closing price
Capitalization
320.75M
75 days until earnings call
CRNX
Price
$32.10
Change
+$0.22 (+0.69%)
Updated
Jun 3 closing price
Capitalization
3.01B
65 days until earnings call
Interact to see
Advertisement

ABEO vs CRNX

Header iconABEO vs CRNX Comparison
Open Charts ABEO vs CRNXBanner chart's image
Abeona Therapeutics
Price$6.27
Change-$0.01 (-0.16%)
Volume$907.83K
Capitalization320.75M
Crinetics Pharmaceuticals
Price$32.10
Change+$0.22 (+0.69%)
Volume$679.69K
Capitalization3.01B
ABEO vs CRNX Comparison Chart
Loading...
ABEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABEO vs. CRNX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABEO is a Buy and CRNX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (ABEO: $6.27 vs. CRNX: $32.10)
Brand notoriety: ABEO and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABEO: 44% vs. CRNX: 67%
Market capitalization -- ABEO: $320.75M vs. CRNX: $3.01B
ABEO [@Biotechnology] is valued at $320.75M. CRNX’s [@Biotechnology] market capitalization is $3.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABEO’s FA Score shows that 0 FA rating(s) are green whileCRNX’s FA Score has 0 green FA rating(s).

  • ABEO’s FA Score: 0 green, 5 red.
  • CRNX’s FA Score: 0 green, 5 red.
According to our system of comparison, ABEO is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABEO’s TA Score shows that 4 TA indicator(s) are bullish while CRNX’s TA Score has 5 bullish TA indicator(s).

  • ABEO’s TA Score: 4 bullish, 5 bearish.
  • CRNX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than ABEO.

Price Growth

ABEO (@Biotechnology) experienced а +2.45% price change this week, while CRNX (@Biotechnology) price change was +8.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

ABEO is expected to report earnings on Aug 18, 2025.

CRNX is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.01B) has a higher market cap than ABEO($321M). ABEO YTD gains are higher at: 12.567 vs. CRNX (-37.219). ABEO has higher annual earnings (EBITDA): -64.95M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. ABEO (110M). ABEO has less debt than CRNX: ABEO (23.1M) vs CRNX (50.8M). CRNX has higher revenues than ABEO: CRNX (760K) vs ABEO (0).
ABEOCRNXABEO / CRNX
Capitalization321M3.01B11%
EBITDA-64.95M-373.49M17%
Gain YTD12.567-37.219-34%
P/E RatioN/AN/A-
Revenue0760K-
Total Cash110M1.27B9%
Total Debt23.1M50.8M45%
FUNDAMENTALS RATINGS
ABEO vs CRNX: Fundamental Ratings
ABEO
CRNX
OUTLOOK RATING
1..100
1465
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
91
Overvalued
PROFIT vs RISK RATING
1..100
10069
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
4586
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABEO's Valuation (61) in the Pharmaceuticals Generic industry is in the same range as CRNX (91) in the Pharmaceuticals Major industry. This means that ABEO’s stock grew similarly to CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (69) in the Pharmaceuticals Major industry is in the same range as ABEO (100) in the Pharmaceuticals Generic industry. This means that CRNX’s stock grew similarly to ABEO’s over the last 12 months.

ABEO's SMR Rating (97) in the Pharmaceuticals Generic industry is in the same range as CRNX (100) in the Pharmaceuticals Major industry. This means that ABEO’s stock grew similarly to CRNX’s over the last 12 months.

ABEO's Price Growth Rating (45) in the Pharmaceuticals Generic industry is somewhat better than the same rating for CRNX (86) in the Pharmaceuticals Major industry. This means that ABEO’s stock grew somewhat faster than CRNX’s over the last 12 months.

ABEO's P/E Growth Rating (100) in the Pharmaceuticals Generic industry is in the same range as CRNX (100) in the Pharmaceuticals Major industry. This means that ABEO’s stock grew similarly to CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABEOCRNX
RSI
ODDS (%)
Bearish Trend 1 day ago
79%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 9 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 3 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
ABEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TILGX28.62N/A
N/A
Nuveen Large Cap Growth R6
TMDIX18.00N/A
N/A
AMG TimesSquare Mid Cap Growth Z
TVLAX11.56N/A
N/A
Touchstone Value A
FOVCX20.74N/A
N/A
First Trust/Confluence Small Cap Val C
JOPPX49.99N/A
N/A
Johnson Opportunity

ABEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABEO has been loosely correlated with ERAS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ABEO jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABEO
1D Price
Change %
ABEO100%
-0.16%
ERAS - ABEO
47%
Loosely correlated
+1.40%
ZYME - ABEO
45%
Loosely correlated
+3.78%
RGLS - ABEO
45%
Loosely correlated
+0.38%
APGE - ABEO
45%
Loosely correlated
+2.06%
CRNX - ABEO
44%
Loosely correlated
+0.69%
More

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+0.69%
XNCR - CRNX
59%
Loosely correlated
+6.53%
IDYA - CRNX
56%
Loosely correlated
+1.98%
DYN - CRNX
56%
Loosely correlated
+4.49%
TRDA - CRNX
55%
Loosely correlated
+1.23%
RVMD - CRNX
55%
Loosely correlated
-0.17%
More